"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Apotex","Apotex Corp.","$4,000,000","$0","$4,000,000","2013","20131118","government-contracting-related offenses","False Claims Act and related","","The Louisiana Attorney General's Office announced that it had obtained a total of $88 million in settlements from 25 pharmaceutical companies to resolve allegations they overcharged the state's Medicaid program.","state","agency action","Louisiana Attorney General","civil","","","","","","Louisiana","","","","","","Canada","","privately held","","pharmaceuticals","generic drugs","https://web.archive.org/web/20131206104321/http://www.ag.state.la.us/Article.aspx?articleID=788&catID=2",""
"Apotex Corp.","Apotex Corp.","$24,100,000","$0","$24,100,000","2020","20200507","competition-related offenses","price-fixing or anti-competitive practices","","Apotex Corp., a generic pharmaceutical company headquartered in Florida, agreed to pay a criminal penalty of $24.1 million under a deferred prosecution agreement relating to fixing the price of the generic drug pravastatin.","federal","agency action","Justice Department Antitrust Division","criminal","deferred prosecution agreement","","","","","","","","","","","Canada","","privately held","","pharmaceuticals","generic drugs","https://www.justice.gov/opa/pr/generic-pharmaceutical-company-admits-fixing-price-widely-used-cholesterol-medication",""
"Apotex Corporation","Apotex Corp.","$49,000,000","$0","$49,000,000","2021","20211001","government-contracting-related offenses","False Claims Act and related","price-fixing or anti-competitive practices","Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","Canada","","privately held","","pharmaceuticals","generic drugs","https://www.justice.gov/opa/pr/pharmaceutical-companies-pay-over-400-million-resolve-alleged-false-claims-act-liability",""
